Buyers Win Cert. In Ranbaxy Generic-Drug Antitrust Case
A Massachusetts federal court on Friday certified classes for two groups of buyers accusing Ranbaxy Pharmaceuticals of delaying generic versions of three different drugs by manipulating the regulatory approval system....To view the full article, register now.
Already a subscriber? Click here to view full article